Bridgefront Capital’s Eli Lilly LLY Stock Holding History

Bridgefront Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Buy	1,547 +886	+134%	+$898K	0.35%	77
2025 Q4	$710K	Buy	+661	New	+$632K	0.18%	193
2024 Q4	–	Sell	-520	Closed	-$461K	–	695
2024 Q3	$461K	Buy	+520	New	+$468K	0.18%	197
2024 Q2	–	Sell	-282	Closed	-$219K	–	589
2024 Q1	$219K	Buy	+282	New	+$201K	0.17%	292
2023 Q4	–	Sell	-562	Closed	-$302K	–	478
2023 Q3	$302K	Buy	+562	New	+$290K	0.21%	198
2022 Q4	–	Sell	-621	Closed	-$201K	–	448
2022 Q3	$201K	Buy	+621	New	+$197K	0.21%	228
2021 Q4	–	Sell	-1,103	Closed	-$255K	–	391
2021 Q3	$255K	Sell	1,103 -1,042	-49%	-$257K	0.27%	181
2021 Q2	$492K	Sell	2,145 -186	-8%	-$37.4K	0.19%	180
2021 Q1	$435K	Buy	+2,331	New	+$456K	0.14%	284

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bridgefront Capital's LLY Position: Q1 2026 in Review

Bridgefront Capital increased its Eli Lilly (LLY) stake by 134% in Q1 2026, buying an estimated $898K and bringing the position to 1,547 shares worth $1.42M. The position accounts for 0.35% of the portfolio, ranked #77.

Bridgefront Capital first reported a position in LLY in Q1 2021 and has held it in 9 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Bridgefront Capital held 1,547 shares of Eli Lilly worth $1.42M as of Q1 2026.
Bridgefront Capital bought 886 Eli Lilly shares in Q1 2026, an estimated $898K.
Eli Lilly made up 0.35% of Bridgefront Capital's portfolio in Q1 2026, its #77 holding.
Bridgefront Capital first reported a position in Eli Lilly in Q1 2021 and has held it in 9 quarters since.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.